450.035 (1r) or by another person under s. 450.035 (1t). (2m) The board shall periodically prepare and distribute letters, bulletins or other types of notice to pharmacists that identify the courses that are approved for purposes of ss. 450.035 (1r) and (2) and 450.085 (1). (3) The board may promulgate rules: (a) Relating to the manufacture of drugs and the distribution and dispensing of prescription drugs. (b) Establishing security standards for pharmacies. (c) Relating to the manufacture, distribution and dispensing of hypodermic syringes, needles and other objects used, intended for use or designed for use in injecting a drug. (d) Necessary for the administration and enforcement of this chapter and ch. 961. (e) Establishing minimum standards for the practice of pharmacy. (f) Establishing procedures for identifying pharmacists and pharmacy technicians impaired by alcohol or other drugs or physical or mental disability or disease and for assisting those pharmacists and pharmacy technicians in obtaining treatment. (3m) (a) The board or its designee may grant a variance to a requirement of this chapter or to a rule promulgated by the board if all of the following are true: 1. The board or its designee determines that a natural or man-made disaster or emergency exists or has occurred. 2. A pharmacist has requested the variance. 3. The board or its designee determines that the variance is necessary to protect the public health, safety, or welfare. (am) If a member of the board disagrees with a decision made by a designee under par. (a) or sub. (3r), the board chairperson shall call a meeting of the board as soon as practicable to review the decision. The board may affirm or modify the designee’s decision. (b) A variance granted under par. (a) shall be for a stated term not to exceed 90 days, except that the board or its designee may
May 22, 2026, are designated by NOTES. (Published 5-22-26)
5
Updated 23-24 Wis. Stats.
extend the variance upon request by a pharmacist if it determines that an extension is necessary to protect the public health, safety, or welfare. (3r) (a) The board or its designee may authorize a pilot program, and may grant a waiver or variance in connection with the pilot program from any rule promulgated by the board, if all of the following are true: 1. The pilot program is related to the practice of pharmacy or prescription verification. 2. The board or its designee determines that the pilot program will improve the safety, quality, or efficiency of the practice of pharmacy in this state. (b) The board or its designee may not authorize a pilot program under par. (a) that lasts longer than 3 years. (4) The board may not promulgate a rule which does any of the following: (a) Limits to a pharmacist the authority to sell or in any way interferes with the sale of nonnarcotic nonprescription drugs that are prepackaged for consumer use and labeled in compliance with all applicable state and federal laws. (b) Interprets s. 448.03 (2) (e) to expand the therapeutic alternate drug selection powers of a pharmacist beyond those specified in s. 450.01 (16) (h). (5) The board may promulgate rules governing pharmacies that are operated as remotely supervised pharmacies. Rules promulgated under this subsection may exempt pharmacies operated as remotely supervised pharmacies from requirements governing pharmacies that are not operated as remotely supervised pharmacies. History: 1985 a. 146; 1987 a. 65; 1995 a. 448; 1997 a. 68; 1997 a. 237 s. 727m; 2005 a. 270; 2015 a. 55, 290, 313; 2021 a. 25, 100, 101; 2025 a. 168.